Citigroup’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
168,356
+57,845
+52% +$396K ﹤0.01% 2953
2025
Q4
$219K Sell
110,511
-2,271,488
-95% -$5.15M ﹤0.01% 3963
2025
Q3
$5.86M Sell
2,381,999
-104,879
-4% -$270K ﹤0.01% 1863
2025
Q2
$6.57M Sell
2,486,878
-227,784
-8% -$612K ﹤0.01% 1682
2025
Q1
$8.17M Buy
2,714,662
+2,330,086
+606% +$7.06M 0.01% 1502
2024
Q4
$985K Buy
384,576
+274,706
+250% +$1.14M ﹤0.01% 3382
2024
Q3
$409K Buy
109,870
+884
+0.8% +$4.09K ﹤0.01% 3857
2024
Q2
$689K Sell
108,986
-1,019,460
-90% -$6.72M ﹤0.01% 3176
2024
Q1
$6.06M Buy
1,128,446
+816,424
+262% +$3.7M 0.01% 1572
2023
Q4
$1.57M Buy
312,022
+305,990
+5,073% +$960K ﹤0.01% 2448
2023
Q3
$10.2K Sell
6,032
-37,482
-86% -$75.3K ﹤0.01% 4536
2023
Q2
$121K Buy
43,514
+35,783
+463% +$101K ﹤0.01% 4148
2023
Q1
$14.1K Sell
7,731
-204,874
-96% -$637K ﹤0.01% 4621
2022
Q4
$1.08M Sell
212,605
-161,039
-43% -$884K ﹤0.01% 2548
2022
Q3
$1.86M Buy
373,644
+358,916
+2,437% +$1.64M ﹤0.01% 2200
2022
Q2
$55K Sell
14,728
-78,444
-84% -$315K ﹤0.01% 4495
2022
Q1
$523K Sell
93,172
-290,323
-76% -$1.78M ﹤0.01% 3469
2021
Q4
$2.33M Buy
383,495
+199,019
+108% +$1.5M ﹤0.01% 2490
2021
Q3
$1.8M Sell
184,476
-115,637
-39% -$1.27M ﹤0.01% 2618
2021
Q2
$4.29M Buy
300,113
+129,865
+76% +$2.15M ﹤0.01% 2030
2021
Q1
$4.04M Buy
170,248
+141,217
+486% +$3.66M ﹤0.01% 1939
2020
Q4
$387K Buy
29,031
+25,853
+813% +$249K ﹤0.01% 4431
2020
Q3
$22K Sell
3,178
-750
-19% -$7.48K ﹤0.01% 6122
2020
Q2
$48K Buy
3,928
+989
+34% +$5.58K ﹤0.01% 6033
2020
Q1
$8K Sell
2,939
-241
-8% -$1.21K ﹤0.01% 7122
2019
Q4
$12K Hold
3,180
﹤0.01% 7139
2019
Q3
$4K Sell
3,180
-1,068
-25% -$1.32K ﹤0.01% 7388
2019
Q2
$4K Sell
4,248
-2,714
-39% -$3.13K ﹤0.01% 7529
2019
Q1
$11K Sell
6,962
-7,051
-50% -$8.85K ﹤0.01% 7214
2018
Q4
$17K Buy
14,013
+8,216
+142% +$18.8K ﹤0.01% 6949
2018
Q3
$22K Buy
5,797
+2,294
+65% +$7.25K ﹤0.01% 7034
2018
Q2
$11K Buy
3,503
+3,244
+1,253% +$12K ﹤0.01% 7147
2018
Q1
$1K Sell
259
-6,812
-96% -$29.9K ﹤0.01% 7443
2017
Q4
$32K Buy
7,071
+3,818
+117% +$18.1K ﹤0.01% 6468
2017
Q3
$18K Buy
3,253
+2,061
+173% +$12.7K ﹤0.01% 6472
2017
Q2
$9K Sell
1,192
-4,986
-81% -$21.5K ﹤0.01% 6565
2017
Q1
$21K Sell
6,178
-16,008
-72% -$79.1K ﹤0.01% 6228
2016
Q4
$127K Buy
22,186
+7,195
+48% +$48K ﹤0.01% 5623
2016
Q3
$117K Buy
14,991
+390
+3% +$2.91K ﹤0.01% 5094
2016
Q2
$91K Sell
14,601
-2,480
-15% -$19.3K ﹤0.01% 5149
2016
Q1
$140K Buy
17,081
+428
+3% +$4.03K ﹤0.01% 5416
2015
Q4
$288K Buy
16,653
+10,352
+164% +$154K ﹤0.01% 4404
2015
Q3
$72K Buy
+6,301
New +$138K ﹤0.01% 5189

Other funds holding IBRX